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Abstract
Studies using dopaminergic and serotonergic agonists or antagonists implicate involvement of
these systems in various aspects of early maternal behavior and postpartum aggression towards an
intruder in rats, both of which are associated with the presence of oxytocin in specific brain
regions. It is unclear however, if or how long-term uptake inhibition of either neurotransmitter
system alone or in combination, affects oxytocin system dynamics or maternal behavior/
aggression. Pregnant women frequently take drugs (antidepressants, cocaine) that induce long-
term reuptake inhibition of dopamine and/or serotonin, thus it is important to understand these
effects on behavior and biochemistry. Rat dams were treated throughout gestation with amfonelic
acid, fluoxetine, or a combination of both, to investigate effects of reuptake inhibition of dopamine
and serotonin systems respectively, on maternal behavior, aggression and oxytocin. The more
appetitive aspects of maternal behavior (nesting, licking, touching) and activity were increased by
the low dose of amfonelic acid, high dose of fluoxetine, or the high dose combination more than
other treatments. Aggression was decreased by amfonelic acid and somewhat increased by
fluoxetine. Dopamine uptake inhibition appears to have a strong effect on hippocampal oxytocin
levels, while receptor dynamics may be more strongly affected by serotonin uptake inhibition.
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1. Introduction
Though there has been considerable interest in the biological basis of maternal behavior for
some time, there are few systematic studies that have examined reuptake inhibition of
specific neurotransmitter systems considering how many women use drugs during
pregnancy, both legal (antidepressants, anti-anxiety medications, or antipsychotics) and
illegal (cocaine), that act as reuptake inhibitors of norepinephrine, dopamine, and/or
serotonin (Cooper et al., 1996; Kessler et al., 1994; Ritz et al., 1990; Thomas and Palmiter,
1997). This is particularly relevant clinically in light of new research on the effects of
prenatal exposure to SSRIs (Moses-Kolko et al., 2005), and the fact that currently the use of
broad spectrum antidepressants which inhibit reuptake of all three systems simultaneously,
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are being proposed for treatment of depression (Skolnick et al., 2003; Beer et al., 2004).
Furthermore, the treatment of clinically depressed schizophrenic and Parkinson’s patients
who are pregnant can also result in reuptake inhibition of multiple neurotransmitter systems
(Lemke et al., 2004; Sawabini and Watts, 2004; Quintin and Thomas, 2004). Given these
facts, the study of the effects of simultaneous reuptake inhibition of various neurotransmitter
systems on maternal behavior requires exploration.
Animal models may prove more useful for these studies given the difficulties of multiple
variable controls in human studies. Reports using rodent models have found that serotonin
and dopamine can both impact various aspects of the oxytocin system, and given the
peptide’s likely role in maternal behavior onset and aggression in rodents, gestational uptake
inhibition of one or a combination of these systems could subsequently alter these behaviors
(Bagdy, 1996; Cunningham et al., 1992; Giordano et al., 1990; Hansen, 1994; Honda et al.,
1985; Kendrick et al., 1992; Lubin et al., 2003a,b; Sarnyai and Kovacs, 1994; Van de Kar et
al., 1995). Oxytocin has been shown to be extremely important to the onset of maternal
behavior, though perhaps not as vital to the maintenance of maternal behavior and evidence
suggests it plays a role in maternal aggression as well (Fahrbach et al., 1985; Lubin et al.,
2003b; Pedersen et al., 1985, 1994; Van Leengoed et al., 1987). Pedersen et al. (1982)
demonstrated that oxytocin administration to ovar-iectomized rats can induce and perpetuate
maternal behavior, while Lubin et al. (2003b) demonstrated that oxytocin antagonist
administration into the central amygdala increases maternal aggression. Johns et al. (2004)
found that gestational treatment with fluoxetine (a serotonin reuptake inhibitor) resulted in a
reduction in oxytocin receptor affinity and an upregulation of oxytocin receptor number in
the amygdala. Several brain regions are suggested as being relevant to maternal behavior
and/or aggression in the rat, including the medial preoptic area (MPOA), ventral tegmental
area (VTA), hippocampus, and amygdala, and reductions in oxytocin in these areas correlate
with deficits in maternal behavior and/or aggression (Ferris et al., 1992; Gaffori and Le
Moal, 1979; Johns et al., 1995, 1997; Kimble et al., 1967; Lubin et al., 2003b; Numan and
Smith, 1984; Numan, 1994a,b).
The direct effects of dopamine (DA) and serotonin (5-HT) reuptake inhibition, alone or in
combination, occurring during pregnancy on subsequent maternal behavior are poorly
understood. The serotonin system has been loosely linked to maternal behavior, with
research suggesting that serotonin agonists alter peripheral oxytocin release, which is
important for lactation (Bagdy et al., 1992; Bagdy and Kalogeras, 1993; Saydoff et al., 1991;
Uvnas-Moberg et al., 1996), and that reduced serotonin levels result in increased aggression
(Coccaro, 1989, 1992; Olivier and Mos, 1992; Olivier et al., 1995). Furthermore, De
Almeida and Lucion (1994) found that when injected acutely (ICV), serotonin receptor
agonists reduce maternal aggression, yet do not impair normal maternal behavior.
Manipulations of the dopamine system have been more strongly associated with alterations
in various aspects of maternal behavior. Dopamine system stimulation through the use of
agonists, particularly D2 receptor agonists, has been shown to promote the release of
peripheral oxytocin (Amico et al., 1992, 1993; Crowley et al., 1992; Parker and Crowley,
1992), while administration of dopamine antagonists results in a significant disruption in
pup retrieval, nest building, and motor activity in general (Byrnes et al., 2002; Giordano et
al., 1990; Keer and Stern, 1999; Silva et al., 2001, 2003; Stern and Keer, 1999). As Stern
and Keer (1999) suggest, this could potentially be due to the dopamine system involvement
in motivation and reward. A 1.5 mg/kg dose of the dopaminergic reuptake inhibitor,
amfonelic acid, enhanced maternal behaviors on postpartum day (PPD) 1 and decreased
maternal aggression on PPD 6 in gestationally treated rat dams and oxytocin levels were
significantly increased in the amygdala of the less aggressive AFA treated dams on PPD 8
(Johns et al., 1995, 1996).
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We are unaware of any other studies examining the effect of both separate and simultaneous
reuptake inhibition of dopamine and serotonin on maternal behavior, aggression, and
oxytocin levels in rodents. Our novel approach seems particularly timely given recent
findings on prenatal exposure to SSRIs and proposed treatments for depression (Moses-
Kolko et al., 2005; Beer et al., 2004). This study reports the effects of gestational treatment
with several doses of relatively selective reuptake inhibitors for dopamine and serotonin
neurotransmitter systems, on maternal behavior/aggression and oxytocin using a previously
established rodent model of behavioral testing.
2. Methods
2.1. Subjects
Virgin female Sprague–Dawley Rats (200–230 g) were group housed in a temperature and
humidity controlled room for a 7-day habituation period prior to breeding. Females were
then individually housed with a sexually active male until conception was noted by the
presence of a sperm plug. On the day a sperm plug was discovered, designated as gestation
day 0, the female was removed from the breeding cage, randomly assigned to treatment or
control groups, individually housed, and provided food (Purina Rat Chow) and water ad
libitum (with the exception of the yoke-fed controls, see Treatment). Singly housed pregnant
females were maintained on a reversed 12:12 h light cycle (lights out at 0900 hours) for 8
days, then transferred to a room with a regular 12:12 h light cycle (lights on at 0700 hours)
for the remainder of the experiment, a procedure that generally results in the majority of
dams delivering their litters during daylight hours (Mayer and Rosenblatt, 1998).
2.2. Treatment
Upon determination of pregnancy, females were randomly assigned to one of eleven
treatment groups, or as a surrogate. Surrogate dams received no treatment but were weighed
every 5 days. Throughout gestation (GD 1–20), all treatment groups received daily
subcutaneous (sc) injections on alternating flanks of the following drugs: 0.9% normal saline
(SAL) in a 1 ml/kg volume at 9:00 A.M. and 4:00 P.M.; 0.625, 1.25, or 2.5 mg/kg amfonelic
acid (AFA, Research Biomedicals Inc., Natick, MA) dissolved in a pH 10 solution (0.1 ml 1
N NaOH and 0.6 ml of 0.1 N HCL in distilled water) once daily at 9:00 A.M. and a normal
saline injection at 4:00 P.M.; 2 mg/kg, 4 mg/kg or 8 mg/kg fluoxetine hydrochloride (FLU,
Sigma, St. Louis MO, USA) dissolved in distilled water at 9:00 A.M. and a normal saline
injection at 4:00 P.M.; or a combined treatment of an AFA injection on one flank and a FLU
injection on the opposite flank at 9:00 A.M. (i.e. low dose AFA/FLU=AFA 0.625/FLU 2
mg/kg; medium AFA/FLU=AFA 1.25/FLU 4 mg/kg; high AFA/FLU=AFA 2.5/FLU 8 mg/
kg), followed by a normal saline injection at 4:00 P.M. Single daily doses of treatment drugs
or the combination of drugs were given because of their long half-life. Afternoon injections
of saline were given to mimic the stress of twice daily injections used in our current
behavioral testing paradigm, and injections were given on alternate flanks to minimize skin
damage. Dams were weighed daily. Food consumption was measured for FLU and yoke-fed
saline groups.
Two separate saline injected control groups were used, a yoke-fed control (SALY) group to
control for the anorexic effects of FLU administration, while another saline control group
(SAL) served as a control for the AFA treatment dams and had free access to food. The
SALY group was given only as much food as the average FLU and AFA/FLU exposed dams
ate on the same particular gestational day. AFA does not generally produce anorexia, but
when paired with FLU may produce this effect.
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AFA was chosen as the dopaminergic reuptake inhibitor because of its non-amphetamine-
like properties, and because unlike other more common DA reuptake inhibitors, it has few
effects on the noradrenergic system. AFA has been described as very selective in vivo for
protecting dopamine storage pool content (Fuller and Perry, 1981). It has also been
suggested that AFA has abuse potential because of its reinforcing effects, which may be
even greater than some other stimulants and opioids (Izenwasser and Kornetsky, 1989;
Porrino et al., 1988). Amfonelic acid has few effects on the adrenergic systems, and at the
doses in the present study, there are no alpha-adrenergic effects and no effect on serotonin
turnover (personal communication, Brian McMillen, Ph.D.). The 2.5 mg/kg dose of AFA
produces significant DA uptake blockade for about 12 h after injection (half life 8–12 h) and
produces no toxic effects on rat dams (Johns et al., 1995).
FLU was chosen as the serotonergic reuptake inhibitor, because while it is selective to the
serotonergic system, it is not selective to one specific receptor subtype (Cooper et al., 1996).
FLU could potentially bind to DA and NE reuptake sites at 10 mg/kg, so the highest dose in
this study (8 mg/kg) was chosen to avoid these effects. FLU has a half-life (including its
metabolites) of approximately 8–15 h in rats (Raap and Van de Kar, 1999), has been
successfully administered to pregnant rats (Montero et al., 1990), and has been used by
women throughout gestation (Goldberg and Nissim, 1994).
All procedures were conducted under federal and University Institutional Animal Care and
Use Committee (IACUC) guidelines for humane treatment of laboratory subjects.
2.3. Maternal behavior testing
Upon delivery of their last pup, designated as PPD 1, the dams were brought in their home
cage to a 10 × 12 ft observation room. The home cage was placed into a 24 × 16 × 20 in
dimly lit testing cubicle, designed to reduce environmental distractions during testing, and
the subject’s pups were removed. Gestational length, weight gain, litter size and weight, and
gender of pups were recorded. Eight male pups born within 12 h to a surrogate dam were
placed in a warm cage above the test cubicles while the dam to be tested habituated to the
room and test chamber for 30 min. After the habituation period, 10 pieces of nesting
material (paper towel strips) were placed at the rear of the cage and the 8 male surrogate
pups were placed in the front of the cage. Untreated male surrogate pups were used to
eliminate the possible effects of differential pup treatment due to prenatal drug exposure or
gender preference. Videotaping with a VHS recorder with low light sensitivity began as
soon as the pups were placed into the cage and continued for 30 min. Any apparent physical
danger to pups would have resulted in removal of the dam and exclusion of the data from
analysis, but this did not occur during behavioral testing. The 11 behaviors of interest, which
have been previously described (Hofler et al., 2003), focus primarily on maternal pup-
directed behavior displayed by the dam, as well as general activity. Behaviors included:
nest-build (dam manipulates paper strips with her mouth or paws); touch/sniff pups (dam
touches pups with her front paws or nose); retrieve pups (dam retrieves 2, 6 or 8 pups from
the front to the back of the cage); self-groom (dam grooms herself with her tongue or paws);
rest off/lie on (dam rests away from the pups or lies flat on top of pups); crouch (dam stands
over the pups with her back arched in the nursing position with stiff straight legs and head
lowered); lick pups (dam licks the pups); rear/sniff (dam rears on hind legs and sniffs the
cage or air); and other (any behavior other than those designated above). Following maternal
behavior testing, dams and their surrogate litters were returned to the colony until PPD 6.
Dams and litters were monitored daily to assure pups were being fed.
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2.4. Maternal aggression testing
On PPD 6, dams and their litters were brought in their home cage to the behavioral
observation room where pups and dams were weighed. Dams and litters were then returned
to their home cages, and the cage placed in the testing cubicle (as used for maternal behavior
testing) and a 5-min chamber habituation period ensued. Following the habituation period, a
smaller male intruder (175–190 g) was placed in the cage on the end opposite the dam and
her litter, and the session was videotaped for a 10-min period. No session had to be
discontinued because of excessive aggression from either the intruder male or dam.
Following testing, the male was removed from the cage, and the dam and pups were
returned to the colony room. A new male was used for each test so that previous experience
of the intruder would not affect their behavior. The 11 aggressive behaviors of interest,
which have been previously described (Lomas et al., 2002; Lubin et al., 2003b) included:
push/box/kick (dam pushes or kicks the intruder); maternal behavior (dam licks pups,
retrieves, or crouches over pups); rough groom (dam grooms intruder male roughly, usually
around head, neck, or back); self-groom (dam grooms herself); lateral/front threat (dam
threatens male while approaching from the side, or threatens face to face); fight/attack (a
quick lunge by the female usually followed by rolling, biting and fur-pulling directed
towards the neck and back regions of the intruder); rear/sniff (dam rears on hind legs and
sniffs the top or sides of cage); nip/bite (dam nips or bites male, but not as part of a fight
attack); chase male (female chases intruder); aggressive posture (dam stands over a
submissive intruder with extended front paws pinning him down); and other (any behavior
other than those included in the categories above). Following testing, dams and litters were
returned to the colony.
2.5. Brain dissection
On PPD 7, at approximately 9:00 A.M., one day following aggression testing, dams were
killed by decapitation. The entire brain was removed and the whole MPOA, hippocampus,
amygdala, and VTA were dissected on ice, weighed, and rapidly frozen and stored at −80 °C
for later oxytocin radioimmunoassay (RIA) as previously described (Johns et al., 1997).
Briefly, brains were coronally sectioned from the ventral side rostral to the optic chiasm
(approximately A7100 according to Konig and Klippel, 1963) and just caudal to the optic
chiasm (approximately A5800) to define the preoptic–anterior hypothalamic area. The
MPOA was dissected by making a horizontal cut ventral to the anterior commissure and
vertical cuts inferior to the lines of lateral ventricles. The brains were sectioned once again
just caudal to the tuber cinereum (approximately A3800) to define the medial basal
hypothalamus. The amygdala was removed from these two sections. The VTA was dissected
from the caudal section by making dorso-ventral cuts medial to the optic tracts with a dorsal
cut at the ventral extent of the central gray and the whole hippocampus was then removed
from the caudal remainder of the brain.
2.6. Oxytocin radioimmunoassay
Brain region tissues were homogenized in cold buffer (19 mM monobasic sodium
phosphate, 81 mM dibasic sodium phosphate, 0.05 M NaCl, 0.1% BSA, 0.1% Triton 100,
0.1% sodium azide, pH 7.4) and centrifuged at 3000 ×g for 30 min. Oxytocin
immunoreactive content was assayed in the supernatant according to a protocol from
Peninsula Labs (Belmont, CA). Samples and standards (0.5–500 pg) were incubated in
duplicate for 16–24 h at 4 °C with rabbit anti-oxytocin serum. They were then incubated for
16–24 h at 4 °C with [125I]-Oxytocin after which time normal rabbit serum and goat anti-
rabbit IgG serum were added and incubated 30 min at room temperature. The [125I]-
Oxytocin bound to the antibody complex was separated from free by a 30-min centrifugation
at 4 °C. The radioactivity in the pellet was measured using a LKB CliniGamma counter,
which calculates the picogram content of OT in each sample from the standard curve. The
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intra-assay coefficient of variance was 4.05% and inter-assay coefficient of variance was
8.95%. The standard curve range was 1–128 pg/tube, and the sensitivity of the assay was
approximately, 0.5 pg/tube. Picograms of oxytocin per milligram of tissue were analyzed
and compared for differences between groups.
2.7. Data analyses
Taped sessions were scored by two independent observers blind to treatment condition with
inter- and intra-reliability set at 90% or better concurrence for frequency and latency, and
80% or better for duration of behaviors displayed by the dam. An “in house” computer
program was used to score and determine the frequency, duration, latency, and sequence of
all relevant behaviors displayed by the rat dams as they occurred on tape. If a particular
behavior of interest was not exhibited by a dam, she was assigned a frequency and duration
of 0, and the highest possible latency for the behavior (1800 s for maternal behavior, 600 s
for maternal aggression). One-way between-groups Analyses of Variance (ANOVA) were
employed to analyze differences in gestational measures, maternal behavior/aggression and
oxytocin levels. Tukey (HSD) tests were employed for all post hoc analyses. Behaviors and
oxytocin levels of AFA treated dams were statistically compared to the SAL control group
in one set of ANOVAs, while behaviors and oxytocin levels of FLU and AFA/FLU treated
dams were compared to their yoke-fed saline controls (SALY) in a second set of ANOVAs.
A third between-groups ANOVA, excluding control groups, followed by specific post hoc
analyses were done for separate comparisons of the effects of AFA vs. AFA/FLU only and
FLU vs. AFA/FLU on maternal behavior and aggression measures. Statistical significance
was set at less than or equal to the 0.05 level (p ≤ 0.05). Data for significant effects is
presented in tables as least squares means ± standard error. Statistically significant group
means are designated in bold print with appropriate letters (small case subscripts for 0.05,
large for 0.01), and differences are described in the text as being different at the p ≤ 0.05 (if
they were between 0.02 and 0.05) and p ≤ 0.01 level. Group data is presented in text first for
separate treatments and their respective control group, followed by group comparisons of
AFA/FLU to AFA and then to FLU exclusive of control groups. Behaviors assessed during
maternal behavior testing are grouped as pup-directed, non-pup directed, and activity and
those for maternal aggression testing are designated as aggressive, defensive, and activity
related behaviors. Group differences in oxytocin levels (picograms/milligram tissue) in each
of the brain regions of interest are presented last.
3. Results
3.1. Gestational variables
As illustrated in Table 1, there were no differences between AFA, FLU, AFA/FLU treated
dams and their respective controls, SAL or SALY, on gestation length, litter size and
weight, male and female pup ratio, and culled litter weight gain. Dams exposed to high
doses of AFA/FLU gained less weight during pregnancy than dams exposed to low doses of
AFA/FLU, FLU, or yoke-fed saline dams [F(3,32)=6.30, p ≤ 0.02]. Dams treated with
medium doses of AFA gained significantly less weight during pregnancy than dams exposed
to low doses of AFA [F(3,34)=3.039, p ≤ 0.04], but this effect may be partially due to the
fact that there were fewer pups born to this group.
3.2. Maternal behavior: AFA vs. SAL
3.2.1. Pup directed maternal behaviors—As indicated in Table 2, there was a
significant overall effect of AFA treatment on the duration of crouching [F(3, 32) = 6.11, p
≤ 0.01], and latency to lick pups [F(3,32)=6.586, p ≤ 0.01]. Post hoc analyses determined
that low dose AFA treated dams crouched for a shorter duration than medium dose AFA (p
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≤ 0.02) and saline treated (p ≤ 0.01), dams and that they began licking their pups sooner
than all other groups (p ≤ 0.01).
3.2.2. Non-pup directed and activity behaviors—There was a significant treatment
effect on the frequency [F(3,32)=3.67, p ≤ 0.02], duration [F(3,32)= 3.47, p ≤ 0.03], and
latency [F(3,32)=4.487, p ≤ 0.01] of self-grooming and on the frequency [F(3,32) =2.987, p
≤ 0.05] and duration [F(3, 32) = 4.17, p ≤ 0.01] of “other” behaviors. Low dose AFA treated
dams self-groomed for a longer duration than medium dose (p ≤ 0.05) and saline treated
dams (p ≤ 0.05) and did so more frequently (p ≤ 0.05, both groups). Medium dose AFA
treated dams also began to groom themselves later in the session than high dose AFA treated
dams (p ≤ 0.01). Low dose AFA treated dams performed “other” behaviors more frequently
(p ≤ 0.04) and for a longer duration (p ≤ 0.01) than saline treated dams.
3.3. Maternal behavior: FLU vs. SALY
3.3.1. Pup directed maternal behaviors—As shown in Table 3, all FLU treatment
dams non-significantly tended to crouch (with the exception of crouch duration of FLU low)
and nest-build less, while they would touch/sniff and lick pups more often than SALY
treated dams. There was a significant effect of treatment on the frequency of touch/sniff
pups [F(6,64)=6.56, p ≤ 0.01]. FLU high dose treatment dams had a higher frequency of
touch/sniff pups than SALY (p ≤ 0.01), FLU low (p ≤ 0.01), and FLU med groups (p ≤
0.05).
3.3.2. Non-pup directed and activity behaviors—There was a significant treatment
effect on the latency [F(6, 63) = 8.47, p ≤ 0.01] to self-groom and duration [F(6,63)=11.63,
p ≤ 0.01] of “other” behaviors. Low dose FLU treated dams began self-grooming later than
FLU med, FLU high, and SALY (p ≤ 0.01) treated dams. FLU high dose dams performed
“other” behaviors for a longer duration than FLU low (p ≤ 0.01), FLU med (p ≤ 0.01), and
SALY (p ≤ 0.01) treated dams.
3.4. Maternal behavior: AFA/FLU vs. SALY
3.4.1. Pup directed maternal behaviors—The high dose AFA/FLU treated dams
generally performed several pup-directed behaviors (lick pups, touch/sniff) at higher rates or
for a longer duration compared to other dams (see Table 3). There was a significant effect of
treatment on the duration of crouching [F(6,63)=2.66, p ≤ 0.03], frequency [F(6,63)=3.79, p
≤ 0.01] and latency [F(3,35)=3.85, p ≤ 0.02] of lick pups, and the frequency [F(3,35)=6.26,
p ≤ 0.01] and duration [F(3,35)=4.83, p ≤ 0.01] of touch/sniff pups. AFA/FLU high dose
treated dams crouched for a shorter duration than AFA/FLU medium dose treatment dams (p
≤ 0.05) and began to lick pups sooner than saline treated dams (p ≤ 0.05), and more
frequently than low (p ≤ 0.05) and medium (p ≤ 0.01) dose AFA/FLU, as well as SALY (p
≤ 0.01) treated dams. AFA/FLU high dose dams also touched pups more frequently than
low dose AFA/FLU (p ≤ 0.05) and SALY (p ≤ 0.01) dams, and for a longer duration than
SALY dams (p ≤ 0.05).
3.4.2. Non-pup directed and activity behaviors—There was a significant treatment
effect on the duration of “other” behaviors [F(6,63)=11.63, p ≤ 0.01]. The high dose AFA/
FLU treated dams performed “other” behaviors longer than AFA/FLU low dose (p ≤ 0.05),
AFA/FLU medium dose (p ≤ 0.01), and SALY treated dams (p ≤ 0.01).
3.5. Maternal behavior: AFA/FLU vs. AFA and FLU
3.5.1. Pup directed maternal behaviors—Table 4 represents differences between AFA
and AFA/FLU, as well as differences between FLU and AFA/FLU, exclusive of saline
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controls. There were significant between groups treatment effects on the frequency
[F(8,78)=4.15, p ≤ 0.01] and duration [F(8,78)=2.81, p ≤ 0.01] of touch–sniff pups,
frequency of lick pups [F(8, 77) = 2.82, p ≤ 0.01], and the frequency [F(8,77) =2.17, p ≤
0.04] and duration [F(8,77)=3.30, p ≤ 0.01] of crouching.
3.5.1.1. AFA/FLU vs. AFA: AFA/FLU high dose treated animals touched their pups more
frequently and for a longer duration than AFA high dams (p ≤ 0.05), and licked their pups
more frequently than AFA low dose treated dams (p ≤ 0.05). Differences were also evident
in AFA/FLU low dose treated dams, which crouched more frequently than AFA medium
treated dams (p ≤ 0.05).
3.5.1.2. AFA/FLU vs. FLU: AFA/FLU high dose treated animals touched their pups more
frequently than FLU low dose dams (p ≤ 0.05), while AFA/FLU low dose treated dams
touched their pups less than FLU high dose treated dams (p ≤ 0.05). Furthermore, AFA/FLU
high dose treated dams touched their pups for a longer duration than FLU low (p ≤ 0.01) and
FLU medium (p ≤ 0.05) dose treated dams, and crouched for a shorter duration than FLU
low treated dams (p ≤ 0.05). AFA/FLU high dose treated dams also licked their pups more
frequently than FLU low, and FLU medium (p ≤ 0.05) dose treatment dams.
3.5.2. Non-pup directed and activity behavior—Significant treatment effects were
found on the latency to begin self-grooming [F(8,77) =6.99, p ≤ 0.01] and the duration of
other behaviors [F(8,77)=5.508, p ≤ 0.01].
3.5.2.1. AFA/FLU vs. AFA: Dams treated with the high dose of AFA/FLU groomed
themselves earlier in the session and performed “other” behaviors longer (duration) than
dams treated with the medium dose of AFA (p ≤ 0.05). AFA/FLU low and medium dose
treatment dams performed “other” behaviors for a shorter duration than AFA low dose
treated dams (p ≤ 0.01).
3.5.2.2. AFA/FLU vs. FLU: Dams treated with the all doses of AFA/FLU groomed
themselves earlier in the session than those treated with the low dose of FLU (p ≤ 0.01).
AFA/FLU high dose treated dams also performed “other” behaviors for a longer duration
FLU low and medium dose treated dams (p ≤ 0.05).
3.6. Maternal aggression: AFA vs. SAL
3.6.1. Aggressive behaviors—There were no significant differences between groups on
any measure of aggressive behavior (See Table 5).
3.6.2. Defensive behaviors—All AFA treated dams threatened for a shorter duration
[F(3,32)=7.20, p ≤ 0.01] and high dose AFA treated dams only threatened intruders less
often [F(3, 32) = 4.04, p ≤ 0.02] than SAL treated dams (p ≤ 0.01).
3.6.3. Activity levels—There were no significant differences between groups on any
measure of activity level.
3.7. Maternal aggression: FLU vs. SALY
3.7.1. Aggressive behaviors—Generally, high dose FLU treated dams tended to attack
intruders more frequently, for a longer duration, and earlier than low and medium dose FLU
groups and controls, though only duration of attack was significantly increased
[F(6,64)=2.36, p ≤ 0.05], as shown in Table 6. Dams treated with the high dose of FLU,
attacked intruders over a longer duration of time than did SALY controls (p ≤ 0.05).
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3.7.2. Defensive behaviors—There was a significant treatment effect on threat duration
[F(6, 64) = 4.60, p ≤ 0.04]. Post hoc analysis indicated that dams treated with the high dose
of FLU threatened intruders for a shorter duration than control dams (p ≤ 0.01).
3.7.3. Activity levels—Treatment effects were evident for the duration of rear/sniff
[F(6,64)=2.65, p ≤ 0.02] and the latency to perform other behaviors [F(3,40)=3.248, p ≤
0.03]. FLU low and medium treated dams rear/sniffed more than SALY dams (p ≤ 0.05). All
FLU treated dams also began performing “other” behaviors later in the session than SALY
dams (p ≤ 0.05).
3.8. Maternal aggression: AFA/FLU vs. SALY
3.8.1. Aggressive behaviors—There were no significant differences on the frequency,
duration, or latency of any aggressive behavior (see Table 6). Interestingly, the AFA/FLU
dams all tended to nip or bite the intruder more than controls (ns).
3.8.2. Defensive behaviors—There were no significant differences in the frequency,
duration, or latency of any defensive behavior.
3.8.3. Activity levels—The frequency [F(6,64)=3.73, p ≤ 0.01] and duration
[F(6,64)=2.65, p ≤ 0.02] of rear/sniff were significantly different between groups, although
general activity (other) was not. The low dose AFA/FLU treated dams had a higher
frequency of rear/sniff compared to AFA/FLU medium treated dams (p ≤ 0.05), and SALY
dams (p ≤ 0.01), and did it longer (duration) than AFA/FLU medium dose (p ≤ 0.05) and
SALY treated dams (p ≤ 0.01).
3.9. Maternal aggression: AFA/FLU vs. AFA and FLU
3.9.1. Aggressive behaviors—Table 7 illustrates significant treatment effects on attack
duration [F(8, 78) = 2.10, p ≤ 0.05], and frequency [F(8, 78) = 4.76, p ≤ 0.01] and latency
[F(8, 78) = 2.49, p ≤ 0.02] of nip/bite.
3.9.1.1. AFA/FLU vs. AFA: AFA/FLU low dose treated dams had higher frequencies of
nip/bite than AFA medium treated dams (p ≤ 0.01).
3.9.1.2. AFA/FLU vs. FLU: AFA/FLU low treated dams attacked for shorter periods
(duration) than FLU high treatment dams (p ≤ 0.05). AFA/FLU medium and low dose dams
had higher frequencies of nip/bite than all FLU treated dams (p ≤ 0.05, 0.01 respectively),
and AFA/FLU medium dose dams also had a shorter latency to nip/bite than FLU high
treated dams (p ≤ 0.05).
3.9.2. Defensive behaviors—Threat frequency was significantly different between
treatment groups [F(8,78)=3.06, p ≤ 0.01].
3.9.2.1. AFA/FLU vs. AFA: Post hoc analysis revealed that AFA/FLU low and medium
dose treated dams threatened more than AFA high dose dams (p ≤ 0.05).
3.9.2.2. AFA/FLU vs. FLU: There were no significant differences between AFA/FLU
treated dams and FLU treated dams on measures of defensive behaviors.
3.9.3. Activity levels—There was a significant treatment effect on frequency of rear/sniff
behavior [F(8,78)=2.59, p ≤ 0.02] and latency to begin “other” behaviors [F(8,78)=4.38, p ≤
0.01].
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3.9.3.1. AFA/FLU vs. AFA: There were no significant differences between AFA/FLU
treated dams and AFA treated dams on activity levels.
3.9.3.2. AFA/FLU vs. FLU: Medium dose AFA/FLU treatment dams had a lower
frequency of rear/sniff behavior than FLU low dose treated dams (p ≤ 0.05). All AFA/FLU
treated dams began performing “other” behaviors earlier than the high dose FLU treated
dams (p ≤ 0.01).
3.10. Oxytocin radioimmunoassay
Mean oxytocin levels (picograms/milligram) and SEM are shown in Table 8. There were no
significant between-group differences in oxytocin levels in the amygdala or MPOA,
although interestingly, the high dose FLU and AFA/FLU treated dams, which were the most
aggressive, had the lowest oxytocin levels in the amygdala. There was a significant
treatment effect on oxytocin levels in the hippocampus [F(3, 35) = 29.164, p ≤ 0.01] and
VTA [F(3,32)=5.3, p ≤ 0.04]. Only significant group differences are presented in text.
3.10.1. AFA vs. SAL—All AFA treated dams exhibited lower levels of oxytocin in the
hippocampus than SAL (p ≤ 0.01).
3.10.2. AFA/FLU vs. SALY—All AFA/FLU treated animals had lower levels of oxytocin
in the hippocampus than SALY dams (p ≤ 0.01). AFA/FLU high dose treated dams had
higher levels of oxytocin in the VTA than SALY dams (p ≤ 0.05).
3.10.3. AFA/FLU vs. FLU—High dose AFA/FLU treated dams had lower levels of
oxytocin in the hippocampus than all FLU treated dams (p ≤ 0.01) and higher levels of
oxytocin in the VTA than medium dose FLU treated dams (p ≤ 0.05). AFA/FLU treated low
and medium dose dams had lower hippocampal oxytocin levels than FLU treated low and
medium dose dams only (p ≤ 0.01).
4. Discussion
Results of the present study, in part support previous work by our lab and others, with
respect to maternal behavior and some forms of aggression, in that increased dopamine
release or chronic reuptake inhibition, have been shown to increase certain aspects of
maternal behavior and decrease aggression (Byrnes et al., 2002; Hansen et al., 1991a,b;
Hansen, 1994; Johns et al., 1995, 1996; Keer and Stern, 1999; Numan, 1994a,b; Silva et al.,
2001; Stern and Taylor, 1991). Dopamine has been strongly associated with both the onset
and maintenance of maternal behavior as well as pup-induced maternal behavior (Byrnes et
al., 2002; Hansen et al., 1991a,b; Hansen, 1994; Keer and Stern, 1999; Numan, 1994a,b;
Olazabal et al., 2004; Silva et al., 2001, Stern and Taylor, 1991). In the present study, while
licking, touching, and activity, all dopamine related behaviors, were increased relative to
controls in all the AFA and AFA/FLU treated dams, crouching seems to be altered through
other systems, which is in agreement with previous findings comparing serotonin and
dopamine antagonists (Keer and Stern, 1999). The duration of crouching was particularly
lower in the low dose AFA and high dose AFA/FLU treatment dams, while licking, nest
building, touching, and activity were increased the most in these two groups, implicating a
dopaminergic influence on at least the appetitive and active aspects of maternal behavior.
Crouching behavior has been shown to be increased following treatment with a single dose
(1.5 mg/kg) of AFA given gestationally (Johns et al., 1996). Though the low dose AFA
dams crouched less in the present study, the two highest doses of AFA did not significantly
alter crouch duration, perhaps suggesting that increased activity levels induced by the AFA
low dose treatment may have interfered with this behavior.
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Serotonin, though more strongly associated with aggression, also affects maternal behavior.
Barofsky et al. (1983) found impairments in lactation and pup retrieval, and higher
incidences of pup cannibalism following specific serotonergic neurotoxin lesions of the
median raphe, a major production site for serotonin. Keer and Stern (1999) reported that
following an intracerebral ventricular (ICV) infusion of a serotonergic antagonist, crouching
in rat dams on PPD 6 was not disrupted. However, when the antagonist was infused directly
into the nucleus accumbens, it increased crouching duration. Furthermore, juvenile rats,
which are more likely to be induced to behave maternally, have been shown to have higher
levels of serotonin than adults in the MPOA, a region relevant to maternal behavior
(Olazabal et al., 2004). In the present study, serotonin reuptake inhibition by FLU slightly
decreased crouching except in the low dose FLU treated dams (2.0 mg/kg) who displayed
the longest duration of crouching by any dams, while all doses of FLU increased licking and
touching compared to controls, especially the high dose group. It appears that uptake
inhibition of dopamine or serotonin systems affects crouching differentially as compared to
the more appetitive aspects of maternal behavior such as licking and touching pups. It is
interesting that the low and medium dose FLU treatment dams had slightly higher rates of
licking and touching pups than control dams, but did not show a corresponding increase in
activity and repetitive self-directed behavior (self-groom). Specifically, only the high doses
of FLU and AFA/FLU and low dose of AFA treatment most significantly affected both
appetitive and activity related pup-directed maternal behaviors. Though we chose a dose of
FLU specifically to avoid effects on the dopamine system, it is possible that some of the
increased activity by the high dose treatment dams was a result of FLU induced dopamine
activity. We did not examine levels of serotonin or dopamine following treatment, but other
studies have found that fluoxetine (10 mg/kg) can alter dopamine levels and that AFA
treatment can alter serotonin levels in specific brain regions depending on the dose and
regiment used (Bymaster et al., 2002; McMillen et al., 1991).
When both neurotransmitter systems were stimulated with the AFA/FLU combination, the
results were very interesting. Dams that received the combined treatment, displayed a
latency to begin maternal behaviors similarly to AFA treated dams generally, but rates and
duration of pup directed maternal behaviors such as crouching and licking were more similar
to FLU, as were their activity levels (other, self-groom). The highest dose of AFA/FLU
treatment produced effects very similar to the low dose AFA treatment on several maternal
behaviors (nest build, lick pups, crouching). Though the high dose AFA/FLU dams had
generally higher activity rates than other AFA/FLU treatment dams, their active maternal
behavior (with the exception of crouch duration) was in fact very good. This would suggest
that with respect to simultaneous serotonin and dopamine reuptake inhibition, at the highest
dose the behavioral effects of AFA/FLU are likely having a greater effect on general activity
than that seen at lower doses, and perhaps the lower duration of crouching reflects the
greater time spent in more appetitive aspects of maternal behavior. These studies in
conjunction with others previously mentioned establish another correlation between
serotonin and maternal behavior, but more research is needed to make specific conclusions.
There have been conflicting findings concerning dopamine and aggressive behavior.
Dopamine transporter knockout mice, which were characterized as being easily aroused by
novelty, did not exhibit higher levels of aggressiveness (Spielewoy et al., 2000). Rat dams
that were given VTA microinfusions of 6-hydroxydopamine (6-OHDA) during lactation
showed a persistent deficit in pup retrieval, but were not impaired with respect to nursing,
nest-building, or maternal aggression (Hansen et al., 1991b), whereas ICV infused 6-OHDA
resulted in hyperemotional and hyper-aggressive behavior in female rats (Sorenson and
Gordon, 1975). Preliminary findings from our lab (Johns et al., 1995) reported that maternal
aggressive behavior following 1.5 mg/kg of AFA given to rats during gestation reduced
maternal aggressive behavior significantly on PPD 6. Similarly, in the present study all three
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doses of AFA decreased the frequency of all aggressive and defensive behaviors compared
to controls, while only slightly increasing the duration of “other” and stereotypical (rear/
sniff) behaviors. This would suggest that hyperactivity alone does not account for the lower
aggressive behavior. Changes in dopamine receptors following AFA treatment were not
examined in this study and dopamine receptor changes in specific brain regions cannot be
ruled out as a factor in behavioral changes.
Gestational treatment with the high dose of FLU was correlated with elevated offensive
(attack) and lowered defensive (threat) behavior compared to control dams as reported
previously (Lomas et al., 2002). All FLU treated dams were less likely to nip/bite or threaten
the intruder and had higher rates of stereotypical behavior (rear/sniff), but performance of
other non-aggressive behaviors was similar to controls. Aggression has been most strongly
linked to serotonin levels, and serotonin agonist administration is correlated with
significantly lower levels of maternal aggression (Olivier and Mos, 1992; Olivier et al.,
1995). Serotonin transporter knockout mice and SSRI-exposed mice display lower levels of
aggression as well (Holmes et al., 2002; Olivier et al., 1995). These findings indicate that
higher synaptic levels of serotonin are correlated with lower levels of aggression. Although
FLU treatment and the resulting serotonergic reuptake inhibition would be expected to
initially increase serotonin availability, over time a decreased release might result in lower
levels. Given that FLU is reported to have relatively long efficacy, it is possible that by PPD
6, levels and receptors are differentially altered. Additionally, lower oxytocin levels in the
amygdala have been associated with increased maternal aggression in lactating dams on
PPD 6 (Johns et al., 1995, 1998), and though oxytocin levels in the amygdala of the high
FLU dose group were not significantly lower than controls, they were lower than most other
groups. It was recently reported that gestational treatment with the same dose and regimen
of FLU treatment used in the present study resulted in a lower affinity for oxytocin receptor
binding in the amygdala of lactating rat dams on PPD 6 (Johns et al., 2004). It may be that
the combined effects of slightly lower oxytocin levels and a lower affinity of the receptor for
oxytocin in the amygdala could affect maternal aggressive behavior in these dams. Much of
the data demonstrating decreases in aggression as a result of increased serotonin levels also
come from studies looking at resident-intruder (RI) aggression, which has motivational and
hormonal effects very different from maternal aggression. Olivier et al. (1995) reported
differing effects on RI and maternal aggression depending on which serotonin receptor
subtype was stimulated by an agonist or antagonist.
The combination of AFA and FLU did not significantly increase maternal aggression, but
the high dose AFA/FLU treatment resulted in slightly higher levels of fight attack, second
only to the FLU high dose treatment, and they also had lower amygdaloidal oxytocin levels
as did the FLU high dose treated dams. Unlike the FLU high dose treatment, gestational
treatment with a combined AFA/FLU high dose treatment did not significantly alter
oxytocin receptor affinity or binding in the amygdala on PPD 6 (Johns et al., 2004). Overall
the AFA/FLU groups look more like FLU treated dams with regard to fighting and more like
AFA treated dams on defensive (threat) and activity related (other, rear/sniff) behaviors.
AFA/FLU treated dams were more likely to nip/bite intruders and did it sooner than all other
dam groups. This was the only behavior that totally differentiated them from all other dams.
Generally, adequate levels of oxytocin in the VTA have been associated with normal
maternal behavior during the very early postpartum period (Numan, 1994a,b). We have not
previously reported oxytocin level changes in the VTA as far out as PPD 6 following
gestational treatment with cocaine or 1.5 mg/kg of AFA (Johns et al., 1997). Since the VTA
is the source of the dopamine neurons of the dopaminergic mesolimbic system, the high
dose AFA/FLU treatment may initiate a dopaminergic–oxytocinergic interaction, which
could possibly result in greater oxytocin release (Sarnyai and Kovacs, 1994; Pedersen et al.,
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1994), although neither AFA nor high FLU doses produced a similar result to the combined
drug which might have been expected.
The biggest treatment effects on oxytocin were seen in the hippocampus, another limbic
region of interest. Oxytocin levels were reduced relative to controls in all groups treated
with AFA alone or in combination with FLU, indicating dopaminergic involvement in these
effects as well. Previously, we have reported that cocaine treatment, which produces
simultaneous reuptake inhibition of dopamine, serotonin, and norepinephrine, results in
reductions in oxytocin levels in the hippocampus (Johns et al., 1993, 1997), which vary
depending on treatment and the time of sacrifice. Although the role of uptake inhibition on
oxytocin levels in the hippocampus are not clear, oxytocin levels in this region have been
reported to affect both drug dependence, tolerance (Sarnyai and Kovacs, 1994) and spatial
learning (Tomizawa et al., 2003). Since so few consistent behavioral effects were found in
all the treatment groups associated with reduced hippocampal oxytocin levels in the present
study, no particular correlations between behavioral and oxytocin data could be made.
Further studies concerning the role of oxytocin in this brain region would prove useful.
It is interesting to speculate whether a behavioral stimulus such as pups or an intruder alters
oxytocin levels as a result of the stimulus or oxytocin changes occur directly from drug
treatment prior to behavior stimulus presentation. If there is a behavioral and biochemical
effect resulting from different drug treatments, then it becomes important to understand if
that treatment resulted in either a static (oxytocin response before stimulus) or dynamic
(oxytocin response after pup or intruder challenge) biological response, but in either case,
effects still are the final result of a specific treatment when all else is held constant. We have
previously noted that oxytocin level changes in the amygdala have the same relationship to
control levels following cocaine treatment, whether measured before or after an aggressive
encounter in the early postpartum period (PPD 6–8). Of course drug treatments in the
present study are different from cocaine on several levels and so are not directly comparable.
The oxytocin response may also be different when testing for the initial onset of maternal
behavior since the pup stimuli are so salient, and thus a time course study would be
necessary to answer this question. What is clear, is that both oxytocin system and overt
behavioral changes, whether static or dynamic, occur in response to different drug
treatments and that the relationship between oxytocin, drugs and behavior is complex and
involves multiple variables.
It would have been preferable to be able to assess direct changes in levels of serotonin and
dopamine in brain regions of interest following drug treatment, but our focus on oxytocin
precluded our doing this. Other studies, while not directly comparable to the present drug
regimens, do suggest that treatment with fluoxetine and amfonelic acid can alter levels of
dopamine, serotonin or their metabolites in various brain regions (McMillen et al., 1991).
The number of dose groups and independent measures of behavior involved in this
experiment necessarily meant there would be a large number of multiple comparisons which
always raises the question of a greater chance of Type I errors. We combined groups with
the same controls where possible to reduce statistical comparisons and have used stringent
post hoc tests (Tukey HSD) to reduce the likelihood of finding significance where there
really is none. Given the typical variability within groups, which reduces the chance of
finding significance and our use of stringent tests, we feel that the differences we report are
fairly robust and present in patterns which are logical given our drug groups.
Effects of noradrenergic uptake inhibition, not reported in the present study, were examined
in pilot studies, but preliminary data indicated few effects on maternal behavior/aggression
or oxytocin (Hofler et al., 2003). This does not negate the possibility that future studies
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could find other effects on different aspects of maternal behavior or oxytocin related to
noradrenergic or combined noradrenergic and serotonergic uptake inhibition.
The differential association of specific maternal behaviors with either reuptake inhibition of
dopamine, serotonin, or both is important and will perhaps lead to future studies examining
how the two systems possibly interact to impact specific aspects of maternal behavior and
aggression, such as motivational vs. activity related behaviors. The present study may prove
to be very clinically relevant, since new treatments for depression may incorporate the use of
combined dopamine and serotonin neurotransmitter uptake inhibition for depression
(Skolnick et al., 2003; Beer et al., 2004). Additionally, the effects of combined reuptake
inhibition during pregnancy will certainly be intensely studied in the future, given recent
reports (Moses-Kolko et al., 2005) of behavioral and physiological effects of SSRIs and
other drugs on newborns which are somewhat similar to effects seen in babies exposed
prenatally to cocaine (Mayes, 2002). It will also be important to further examine exactly
how these systems impact the oxytocin system across different brain regions and whether
those changes are time and stimulus dependent. Recently, human studies are emerging
suggesting a more relevant role for oxytocin in maternal care than might have been
previously suspected in humans (Light et al., 2001, 2004).
We have now demonstrated that dopamine reuptake inhibition generally alters the more
appetitive aspects of maternal behavior and general activity but has relatively few effects on
crouching and maternal aggression, other than suppression of aggression by dopaminergic
inhibition. Behavioral data suggests a stronger dopaminergic influence on activity related
maternal behaviors, but crouching behavior seems to be affected differentially with much
less of a dopaminergic influence. The relevance this work might have to the human drug use
during pregnancy (legal and illegal) remains to be seen, but for previously mentioned
populations may prove very timely.
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